SCHEMBL3720707

SCHEMBL3720707

COP(=O)(COCCn1cnc2c(N)ncnc21)OC(=O)C(C)(C)C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.76
ABCB11 O95342 1/20 0.76
POLA1 P09884 1/20 0.76
POLG P54098 1/20 0.76
FAP Q12884 1/20 0.76
FGFR1 P11362 3/20 0.65
NSD3 Q9BZ95 2/20 0.49
ADCY5 O95622 1/20 0.48
ENPP1 P22413 1/20 0.47
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ADORA2A P29274 4/20 0.46
ADORA1 P30542 2/20 0.46
ADORA2B P29275 1/20 0.46
CYP3A4 P08684 1/20 0.46
PI4KA P42356 1/20 0.46
PI4K2B Q8TCG2 1/20 0.46
PI4K2A Q9BTU6 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28797052 0.88 FGFR1 (0.74) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL29372789 0.86 FAP (1.00) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL29729 0.86 FAP (1.00) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL5845498 0.86 FAP (1.00) SLC22A6ABCB11POLA1POLGFAP
Adefovir SCHEMBL28809752 0.86 FGFR1 (0.78) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL3719079 0.85 FAP (0.98) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL3646944 0.85 FAP (0.98) SLC22A6ABCB11POLA1POLGFAP
SCHEMBL20718818 0.85 SLC22A6 (0.77) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL457147 0.83 FAP (0.93) SLC22A6ABCB11POLA1POLGFAP
Adefovir Dipivoxil SCHEMBL3745803 0.83 FAP (0.93) SLC22A6ABCB11POLA1POLGFAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010110506-A1 DH-TYPE CRYSTALLINE FORM OF ADEFOVIR DIPIVOXIL, PREPARING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR ANTIVIRAL AGENT COMPRISING THE SAME DAE HE CHEMICAL CO.,LTD. (KR) 2010-09-30 WO disclosed